UNH
2nd
Unitedhealth
$330.47Bn
365.16
-0.59%
+4.84%
Optum Health delivers clinical care through primary, specialty, surgical, chronic, and behavioral health services, operating in outpatient and clinic settings.
CVS
2nd
Cvs Health
$108.89Bn
85.20
-0.61%
+10.84%
CVS delivers outpatient care through more than 1,000 walk-in and primary care medical clinics, including MinuteClinic and Oak Street Health value-based primary care centers.
HCA
HCA Healthcare
$92.33Bn
423.61
-0.78%
-0.58%
HCA Healthcare operates a vast network of 190 hospitals, including 179 general acute care hospitals with over 50,000 licensed beds, as well as behavioral and rehabilitation hospitals. Its primary revenue is generated from facility-based inpatient and surgical care reimbursed by Medicare, Medicaid, and private insurers.
ELV
2nd
Elevance Health
$82.79Bn
381.80
-1.80%
+14.77%
Through its Carelon Services segment, the company offers virtual care capabilities to internal and external clients as part of its whole health solutions.
CI
2nd
Cigna
$70.83Bn
268.05
-1.39%
-8.09%
The Evernorth Health Services segment provides care services including virtual care and behavioral health support, delivering clinical services remotely to patients.
NTRA
Natera
$58.66Bn
408.47
-1.17%
+152.75%
Natera operates as a diagnostics company that provides clinical laboratory and genetic testing services, generating the vast majority of its revenue from processing millions of tests. Its business model involves performing molecular and bioinformatics analysis on patient samples for oncology, women's health, and organ health, billing for these diagnostic-testing services.
HUM
2nd
Humana
$45.57Bn
379.52
-0.53%
+53.80%
Through its CenterWell segment, the company operates primary care clinics focused on seniors, such as Conviva Senior Primary Care and CenterWell Senior Primary Care, delivering outpatient healthcare services.
IDXX
2nd
Idexx Laboratories
$40.84Bn
517.75
-0.85%
-16.51%
The company operates outside reference laboratory services, providing diagnostic and consulting services to veterinary clinics and producers.
CNC
2nd
Centene
$30.12Bn
60.98
-1.87%
+70.62%
The company provides clinical healthcare services through its Community Medical Group and Denova Collaborative Health, as well as behavioral health services previously offered by Magellan Health.
DGX
Quest Diagnostics
$25.51Bn
231.09
-0.84%
+26.92%
Quest Diagnostics provides clinical laboratory and diagnostic testing services, generating revenue primarily from fees charged for laboratory testing. The company offers a broad menu of routine and specialty tests in areas such as cardiology, oncology, and genetics.
LH
Labcorp Holdings
$24.64Bn
304.60
-1.14%
+9.15%
Labcorp's Diagnostics Laboratories segment performs over 750 million tests annually, providing clinical, genetic, and anatomic pathology services to physicians, hospitals, and patients. This core activity of running tests on patient samples and billing payers per test aligns directly with the Diagnostic Labs classification.
GH
Guardant Health
$23.35Bn
174.75
-2.02%
+178.93%
Guardant Health operates clinical laboratories and generates revenue primarily from providing diagnostic testing services, such as the Guardant360 CDx and Shield tests, to healthcare providers and hospitals. The company bills payers and patients for these clinical laboratory services.
PHG
2nd
Koninklijke Philips
$22.93Bn
23.81
-2.54%
-13.86%
The Connected Care segment provides sleep and respiratory care solutions, including Philips Respironics devices for sleep apnea and chronic respiratory conditions used in home settings.
THC
Tenet Healthcare
$20.47Bn
254.21
-0.52%
+26.26%
Tenet Healthcare operates 50 acute care and specialty hospitals providing inpatient services such as emergency care, intensive care, and specialized treatments in cardiology and neurosciences. Revenue is generated from hospital admissions and surgical procedures reimbursed by Medicare, Medicaid, and commercial insurers.
LDOS
2nd
Leidos Holdings
$15.31Bn
122.01
+0.12%
-36.33%
Through its managed health services, the company deploys a national footprint of health clinics and providers to conduct medical, disability, and behavioral health examinations for the Department of Veterans Affairs.
TEM
Tempus AI
$13.40Bn
76.50
-6.59%
-13.06%
Tempus AI operates a laboratory network that performs genomic and molecular testing, including next-generation sequencing and PCR, for oncology and cardiology patients. It generates primary revenue by providing these diagnostic testing services to hospitals, physicians, and other healthcare providers.
ICLR
2nd
Icon
$12.39Bn
161.85
-4.79%
-15.84%
The company operates a Laboratory Services segment that delivers high-value clinical testing services, including bioanalytical, biomarker, and central laboratory capabilities for vaccine development and oncology research.
EHC
Encompass Health
$11.75Bn
119.07
-2.03%
-4.38%
Encompass Health is the largest owner and operator of inpatient rehabilitation hospitals, operating 173 facilities with 11,465 licensed beds. Its revenue is primarily derived from facility-based inpatient care reimbursed by Medicare, Medicaid, and private insurers.
BTSG
BrightSpring Health Services
$11.31Bn
57.26
+0.90%
+91.89%
BrightSpring delivers care in the home and residential settings, specifically providing home health, hospice, rehabilitation therapy, and personal care services. The profile explicitly states that it serves patients in their own homes, senior living communities, and skilled nursing facilities.
DVA
Davita
$11.28Bn
176.30
+0.75%
+32.69%
DaVita primarily operates a vast network of freestanding outpatient dialysis centers and provides physician practice management and specialty care for patients with end-stage renal disease. Its core revenue is generated from per-procedure dialysis treatments delivered in these outpatient clinic settings.
ENSG
Ensign
$9.88Bn
169.63
-1.38%
-2.76%
The company generates approximately 95.6% of its revenue from the operation of skilled nursing facilities, providing short and long-term nursing care for the elderly and patients with chronic conditions. It also operates senior living units providing residential accommodations and assistance in activities of daily living.
UHS
Universal Health Services
$9.05Bn
175.16
+0.49%
-13.93%
Universal Health Services owns and operates 375 inpatient facilities, including 29 inpatient acute care hospitals and a surgical hospital. Revenue is generated from facility-based inpatient and surgical care reimbursed by Medicare, Medicaid, and commercial payers.
CAI
Caris Life Sciences
$8.01Bn
28.35
-7.44%
-6.53%
Caris Life Sciences generates primary revenue from selling molecular profiling tests, including tissue and blood-based genomic profiling (MI Profile, Caris Assure), to physicians and hospitals. This activity constitutes providing clinical laboratory and diagnostic testing services for cancer detection and treatment monitoring.
HNGE
Hinge Health
$7.85Bn
97.94
+0.65%
+100.90%
Hinge Health delivers clinical musculoskeletal care and prescriptions remotely via a virtual care team of licensed physical therapists, physicians, and health coaches. Its revenue is generated through subscription contracts with employers and health plans for access to this remote care platform.
CHWY
2nd
Chewy
$7.12Bn
17.73
-2.58%
-55.16%
Chewy provides remote clinical care and prescriptions through its 'Connect with a Vet' telehealth service, allowing customers to consult with licensed veterinarians.
HIMS
Hims & Hers Health
$6.84Bn
29.31
-1.61%
-47.95%
The company operates a consumer-first health platform providing telehealth consultations that connect patients with licensed healthcare professionals for prescriptions. Its revenue is primarily generated through subscription-based sales of medications and services delivered remotely via its digital platform.
CHE
Chemed
$6.58Bn
503.08
-0.38%
+14.17%
The company operates VITAS, which provides hospice and palliative care services to elderly patients, with revenue primarily reimbursed by Medicare and Medicaid on a per diem basis.
PACS
Pacs
$6.49Bn
41.02
-1.30%
+192.37%
PACS Group operates 321 post-acute care facilities providing skilled nursing care, assisted living, and independent living options. Its revenue is derived from Medicare, Medicaid, and private pay for services delivered in these residential settings.
GRAL
Grail
$5.92Bn
132.56
-5.40%
+113.60%
GRAIL provides clinical diagnostic testing services through its Galleri blood-based test, which is sold to employers, health systems, and payors. The company operates a high-capacity laboratory capable of processing up to one million tests per year to provide these diagnostic results.
RDNT
RadNet
$5.32Bn
67.70
-1.80%
-13.19%
RadNet operates 418 freestanding outpatient imaging centers providing MRI, CT, PET, and X-ray exams. Revenue is generated from fees for these procedures paid by commercial insurers, Medicare, Medicaid, and patients.
SHC
Sotera Health
$5.17Bn
18.12
-2.00%
+11.92%
The company operates Nelson Labs, which provides outsourced microbiological and analytical chemistry testing, as well as routine sterility and quality control testing for medical device and pharmaceutical customers.
BLLN
BillionToOne
$4.95Bn
105.76
-0.64%
—
BillionToOne provides clinical molecular diagnostic testing services, specifically prenatal and oncology tests, and generates revenue from reimbursement by insurance, government programs, and patients. Its core business is performing these tests (e.g., UNITY suite and Northstar Select) on patient samples rather than selling the diagnostic machines themselves.
CON
Concentra Group Holdings Parent
$4.46Bn
34.97
+1.57%
+67.80%
Concentra operates a nationwide network of 628 stand-alone occupational health centers and 411 onsite health clinics providing outpatient care. Revenue is generated from per-visit services such as workers' compensation injury care, physical examinations, and drug screenings delivered in these clinic settings.
ADPT
Adaptive Biotechnologies
$4.35Bn
27.37
-5.29%
+87.98%
The company generates significant revenue through clinical diagnostic testing, specifically its FDA-authorized clonoSEQ assay used by clinicians, hospitals, and cancer centers for minimal residual disease detection in lymphoid malignancies.
CRVL
2nd
Corvel
$3.80Bn
74.72
+0.23%
+1.56%
The company provides case management and utilization management services to monitor care quality for claimants. These activities involve the coordination and management of outpatient healthcare services delivered through its network of over 1,200,000 providers.
IRTC
iRhythm Holdings
$3.66Bn
111.05
-2.30%
-33.68%
iRhythm generates the majority of its revenue from providing ambulatory cardiac monitoring services through its own Medicare-enrolled independent diagnostic testing facilities. The company collects ECG data, processes it using proprietary software, and delivers diagnostic reports to physicians, billing third-party payers per monitoring episode.
VCYT
Veracyte
$3.55Bn
44.19
-4.02%
+22.04%
Veracyte operates CLIA certified laboratories in South San Francisco, San Diego, and Austin to perform laboratory developed tests such as Afirma and Decipher Prostate. The majority of its revenue is generated from these diagnostic-testing service fees paid by Medicare and private commercial payers.
NHC
National Healthcare
$3.51Bn
224.26
+1.59%
+79.93%
The company's primary revenue (96.8%) comes from healthcare services, specifically operating skilled nursing facilities, assisted living, independent living, and homecare and hospice agencies. These activities match the H-15 description of delivering care in residential settings and the home.
CDNA
CareDx
$3.41Bn
66.23
+1.89%
+341.53%
CareDx generates significant revenue from providing clinical diagnostic testing services, such as AlloSure Kidney and AlloMap Heart, which are performed in its Brisbane, California laboratory and reimbursed by Medicare and private payers.
WRBY
2nd
Warby Parker
$3.39Bn
27.50
-0.94%
+1.36%
The company provides professional eye exams and vision tests conducted by clinicians within its physical retail locations.
OPCH
Option Care Health
$3.38Bn
22.58
+0.40%
-17.11%
Option Care Health is the largest independent provider of home and alternate site infusion services, delivering clinical management and nursing support where the patient lives. Its revenue is derived from Medicare, Medicaid, and managed care reimbursements for home-based infusion therapy and nursing services.
CURLF
2nd
Curaleaf Holdings
$2.72Bn
10.28
-0.19%
+17.75%
The company operates a medical cannabis clinic in the United Kingdom, providing direct medical services and care to patients in a clinic setting.
AVAH
Aveanna Healthcare Holdings
$2.71Bn
12.43
+0.16%
+38.42%
Aveanna provides home-based clinical care including private duty nursing for medically complex children and adults, as well as home health and hospice services for elderly populations. These services are delivered in the patient's home and reimbursed by Medicaid, Medicare, and commercial insurers.
NEOG
2nd
Neogen
$2.66Bn
12.24
-4.38%
+111.03%
The company provides standalone genomics testing services to breed associations, universities, and commercial laboratories worldwide.
BKD
Brookdale Senior Living
$2.59Bn
10.85
+0.09%
+26.75%
Brookdale operates senior living communities providing independent living, assisted living, and memory care, which are residential settings where patients live. Revenue is generated from resident fees paid by private individuals and government reimbursement programs like Medicare and Medicaid.
PRVA
Privia Health
$2.53Bn
20.03
+1.73%
-19.82%
Privia Health operates as a physician enablement company that organizes providers into Medical Groups and manages care delivery across more than 1,300 practice locations. It generates significant revenue from fee-for-service patient care, capitated payments, and management fees for providing practice support and revenue cycle management to physician groups.
ACHC
Acadia Healthcare Company
$2.45Bn
26.93
-2.07%
+9.69%
Acadia operates acute inpatient psychiatric facilities that provide 24-hour observation and crisis stabilization for severe psychiatric diagnoses. These are licensed inpatient facilities where revenue is derived from facility-based care reimbursed by Medicaid, Medicare, and commercial insurers.
NEO
Neogenomics
$2.27Bn
17.78
-3.16%
+103.90%
NeoGenomics operates a network of cancer-focused testing laboratories providing clinical oncology diagnostic testing, including molecular and NGS testing. Its revenue is generated through diagnostic-testing service fees for services like cytogenetics, FISH, and flow cytometry sold to healthcare providers and hospitals.
WGS
GeneDx Holdings
$2.11Bn
70.96
-1.85%
-37.45%
GeneDx generates its primary revenue from the sale of diagnostic test reports for exome and genome sequencing, such as ExomeDx and GenomeDx. The company operates CLIA-certified high-complexity laboratories to provide these clinical laboratory and genetic testing services to hospitals, clinics, and clinicians.
MD
Pediatrix Medical
$2.09Bn
25.78
+0.16%
+51.65%
Pediatrix provides physician services specializing in newborn, maternal-fetal, and pediatric subspecialty care delivered in clinical and hospital-based settings. Its revenue is generated through patient service fees for these outpatient and specialty physician services rendered to expectant mothers and infants.
ADUS
Addus HomeCare
$2.09Bn
111.70
+1.05%
-3.60%
Addus HomeCare provides in-home care services including personal care, hospice, and home health to elderly and disabled individuals. Its revenue is derived from Medicare, Medicaid, and private pay for services delivered where the patient lives, such as non-medical assistance with daily living and palliative care.
LIFE
Ethos Technologies
$2.08Bn
32.57
-2.98%
—
Ethos Technologies delivers clinical care and remote patient monitoring services for chronic conditions like heart failure and diabetes. It employs a team of registered nurses and care managers to monitor patient data and initiate outreach, which aligns with the delivery of remote clinical care.
FMS
Fresenius Medical Care AG
$2.07Bn
22.25
-0.58%
-16.42%
The company operates the world's largest network of 3,601 dialysis centers, providing in-center kidney replacement therapies and outpatient vascular care. This segment, Care Delivery, serves nearly 300,000 patients through a global network of clinics and physician partnerships.
PGNY
Progyny
$1.92Bn
24.85
-1.35%
+17.11%
Progyny delivers healthcare services by managing a selective network of healthcare providers for fertility, pregnancy, and postpartum care. It earns revenue through per-member-per-month charges for care management services and clinical support delivered to members of its employer-sponsored programs.
SNDA
Sonida Senior Living
$1.79Bn
37.79
+0.40%
+36.72%
Sonida Senior Living operates senior housing communities providing independent living, assisted living, and memory care services. It generates revenue through residential fees for housing and care services provided to residents aged 75 and older.
SGRY
Surgery Partners
$1.73Bn
13.23
-4.61%
-37.54%
Surgery Partners operates a national network of ambulatory surgery centers, urgent care facilities, and multi-specialty physician practices. Its revenue is primarily derived from facility fees for outpatient surgical procedures and related ancillary care provided in these clinic settings.
PSNL
Personalis
$1.72Bn
16.17
-0.68%
+134.01%
Personalis provides clinical laboratory and diagnostic testing services, specifically cancer genomic testing, through its CLIA-certified and CAP-accredited high-complexity laboratory. Its revenue is generated from performing tests such as NeXT Personal Dx and NeXT Dx for pharmaceutical companies, diagnostic partners, and cancer patients.
ASTH
2nd
Astrana Health
$1.72Bn
34.91
-1.86%
+23.97%
The company's Care Delivery segment operates more than 60 clinics providing primary care, specialty care, urgent care, imaging, and ambulatory surgery. These are outpatient services delivered in a clinic setting, generating fee-for-service revenue.
ALHC
2nd
Alignment Healthcare
$1.60Bn
7.74
-5.15%
-53.98%
Through its Care Anywhere segment, the company employs its own physicians, advanced practice clinicians, and behavioral health coaches to deliver proactive, cross-disciplinary care. This represents a substantive operational business line of providing outpatient healthcare services to its members.
AZTA
2nd
Azenta
$1.51Bn
34.48
-1.18%
+9.18%
The Multiomics segment provides clinical and research diagnostic services, specifically gene sequencing (Next Generation and Sanger), gene synthesis, and bioinformatics services.
ARDT
Ardent Health
$1.46Bn
10.26
-0.58%
-21.56%
Ardent Health operates a network of 30 acute care hospitals and generates revenue from inpatient acute care reimbursed by Medicare, Medicaid, and commercial health plans.
NUTX
Nutex Health
$1.45Bn
212.31
+0.31%
+103.36%
Nutex Health owns and operates a network of micro hospitals and specialty hospitals that provide 24/7 inpatient care, emergency room treatment, and behavioral health support. Revenue is primarily generated from facility fees paid by federal agencies, private insurers, and patients for these inpatient and surgical services.
HCSG
2nd
Healthcare Services
$1.40Bn
20.58
+0.64%
+26.65%
The company provides professional dietitian services and manages dietary departments to meet residents' medical and nutritional needs in outpatient and long-term care settings.
AGL
2nd
Agilon Health
$1.38Bn
82.41
+3.39%
+229.64%
The company partners with anchor physician groups to deliver primary care and total care approaches to patients in outpatient settings. It provides the people, processes, and care coordination tools necessary to operate these healthcare services.
PNTG
Pennant
$1.35Bn
38.79
-0.54%
+52.72%
Pennant Group operates 172 home health and hospice agencies and 63 senior living communities, providing care where the patient lives. Its revenue is derived from nursing, therapy, and residential care reimbursed by Medicare, Medicaid, and private pay sources.
EYE
2nd
National Vision Holdings
$1.30Bn
16.40
+0.12%
-43.64%
The company provides clinical eye exam services to consumers, which are delivered in an outpatient clinic setting within its retail locations.
OMDA
Omada Health
$1.24Bn
20.41
-1.92%
-8.97%
Omada Health delivers virtual care programs for chronic conditions like diabetes and hypertension, employing health coaches and licensed physical therapists to provide remote clinical care. Its revenue is generated through contracts with employers and health plans for these remote consultation and monitoring services.
USPH
U S Physical Therapy
$1.23Bn
82.60
-3.74%
-3.95%
The company operates outpatient physical, speech, and occupational therapy clinics. Revenue is primarily generated from patient service payments for care delivered in these outpatient clinic settings.
INNV
InnovAge Holding
$1.20Bn
8.80
+0.00%
+69.56%
InnovAge provides comprehensive in-home care (skilled, unskilled, and personal) and supportive services designed to keep frail seniors in their homes and communities. The profile explicitly states that 93% of participants live safely in their homes, which aligns with the delivery of care where the patient lives.
OPK
2nd
Opko Health
$1.17Bn
1.57
-2.48%
+1.29%
Through its BioReference subsidiary, the company operates clinical laboratory operations providing routine and specialized diagnostic testing services, including the proprietary 4Kscore prostate cancer test.
GDRX
2nd
GoodRx Holdings
$1.11Bn
3.27
-0.61%
-34.99%
The company generates revenue from telehealth visits offered via its subscription services, where patients pay for virtual consultations with healthcare professionals.
ODD
2nd
Oddity Tech
$1.08Bn
18.92
+1.39%
-69.07%
The company operates METHODIQ, a medical telehealth platform that provides personalized skin assessments and high-efficacy dermatology treatments via a tracking app.
CSTL
Castle Biosciences
$1.08Bn
35.26
-0.76%
+53.17%
Castle Biosciences operates as a molecular diagnostics company that provides clinical laboratory testing services, such as DecisionDx-Melanoma and TissueCypher, to clinicians. Its revenue is generated from diagnostic-testing service fees billed to third-party payors, Medicare, and patients.
UTI
2nd
Universal Technical Institute
$1.05Bn
19.03
+1.93%
-39.89%
Through its Concorde Career Colleges segment, the company provides education and training in allied health, dental, nursing, and diagnostic fields, including clinical externships in clinical settings.
TDOC
Teladoc Health
$1.03Bn
5.66
-2.41%
-27.44%
Teladoc Health provides virtual primary, urgent, chronic, and mental health services, as well as online counseling via BetterHelp. Its revenue is derived from per-member-per-month access fees from employers and insurers, as well as visit fees and self-pay subscriptions.
TALK
Talkspace
$870.58Mn
5.25
+0.00%
—
Talkspace delivers clinical behavioral healthcare, including virtual psychotherapy and psychiatry, remotely via a web and mobile platform. It generates revenue through per-member-per-month fees and subscriptions from payors, enterprises, and individual consumers for these remote clinical services.
DNA
2nd
Ginkgo Bioworks Holdings
$795.75Mn
12.49
-2.65%
-14.86%
Through its Biosecurity segment, specifically the Canopy and Horizon offerings, the company provides genomic surveillance, pathogen detection, and biomonitoring services to government customers.
AHCO
AdaptHealth
$774.21Mn
5.68
+0.71%
-37.65%
AdaptHealth provides healthcare-at-home solutions, including the delivery, setup, and clinical support of medical equipment and supplies directly in patients' homes. Its business model focuses on home-based care for patients managing chronic conditions like sleep apnea, respiratory disease, and diabetes, as well as those transitioning from acute care to home.
STLN
Starling Oncology
$624.92Mn
6.22
-1.58%
+78.74%
The company operates a network of oncology clinics providing physician services, infusion therapy, and radiation therapy in an outpatient setting. It generates revenue through fee-for-service billing for these procedures and value-based payments from payers for managing outpatient cancer care.
FLGT
Fulgent Genetics
$586.07Mn
21.30
-3.27%
-9.36%
Fulgent Genetics operates a laboratory services business that performs anatomic pathology and molecular diagnostics, generating the majority of its revenue from fees charged for laboratory tests performed for hospitals, reference labs, and institutional clients.
KIDS
2nd
Orthopediatrics
$566.32Mn
21.69
-2.60%
+17.75%
The company operates orthotic and prosthetic clinics that provide non-surgical bracing and related clinical services to patients. These services are delivered in a clinic setting, distinct from inpatient hospital care.
YDES
2nd
YD Bio
$552.86Mn
7.81
+5.26%
-56.42%
The company creates noninvasive diagnostic tests analyzing cfDNA methylation patterns to detect pancreatic and breast cancers, which are offered as laboratory developed tests to licensed health care providers.
WOOF
2nd
Petco Health & Wellness Company
$546.15Mn
2.20
-3.08%
-43.73%
The company provides clinical veterinary care through approximately 300 full-service veterinary hospitals and 1,600 Vetco clinics, delivering preventive and therapeutic care in an outpatient setting.
SBC
SBC Medical Group Holdings
$520.07Mn
5.07
+2.63%
+18.18%
The company owns and operates cosmetic treatment centers in Vietnam and California, and provides comprehensive management services to a network of 164 franchisee clinics. These clinics deliver outpatient cosmetic medical services, including surgery, dermatology, and dentistry, which fits the description of healthcare services delivered in a clinic setting.
MCTA
2nd
Charming Medical
$474.00Mn
29.35
+0.00%
—
The company employs registered Chinese medicine practitioners to provide TCM-inspired therapies for health improvement needs, including menstrual irregularities, menopausal care, and breast health, delivered in its wellness centers.
SRTA
Strata Critical Medical
$427.29Mn
4.83
-5.48%
-6.40%
Strata provides clinical services including surgical organ recovery, organ placement, and cardiac care perfusion to transplant centers and cardiovascular surgery centers. These services are delivered in outpatient or clinic settings (such as hospitals and organ procurement organizations) and are billed on a fee-for-service or retainer basis.
MYGN
Myriad Genetics
$388.14Mn
4.06
-5.80%
-47.48%
Myriad Genetics operates as a molecular diagnostics company that provides clinical laboratory testing services, such as the GeneSight test for mental health and MyRisk for hereditary cancer. Its revenue is derived from performing these diagnostic tests on patient samples and billing healthcare providers and patients.
CYH
Community Health Systems
$386.37Mn
2.74
-4.20%
-12.46%
Community Health Systems owns or leases 69 affiliated hospitals with more than 10,000 beds and provides general acute care, emergency room, and critical care services. Inpatient services account for 47.9 percent of its total net operating revenues.
EVH
Evolent Health
$384.40Mn
3.40
-2.02%
-57.66%
Evolent Health delivers specialty care management services for complex conditions like cancer and cardiovascular disease, supporting physicians and providers in delivering evidence-based care. Its revenue is generated through service fees and capitation arrangements for managing patient care in outpatient and specialty settings.
AUNA
Auna
$369.32Mn
4.99
+0.00%
-26.07%
Auna operates a network of high and medium complexity hospitals in Mexico, Peru, and Colombia, generating revenue from inpatient stays and surgeries.
VMD
Viemed Healthcare
$345.84Mn
9.08
-0.22%
+31.02%
Viemed delivers clinical care, therapy, and chronic disease management in the home, specifically for respiratory chronic care and women's health. Its revenue is derived from Medicare, Medicaid, and private insurance for services delivered where the patient lives.
PRE
2nd
Prenetics Global
$308.44Mn
21.95
-5.10%
+50.34%
The CircleDNA brand complements its consumer genetic testing with tele-consultations and a mobile application to provide health insights and results remotely to users.
AHG
Akso Health
$290.80Mn
1.02
+13.33%
-39.29%
The company operates the Tianjin Deyihui Online Hospital and Tianjin Deyihui Clinic, which provide remote clinical services including teleconsultations and electronic prescriptions. This aligns with the delivery of clinical care and prescriptions to patients remotely.
TBI
2nd
TrueBlue
$288.91Mn
9.49
+3.15%
+49.92%
Through its PeopleSolutions segment and the HSP brand, the company provides healthcare staffing, offering short-term, long-term temporary, and permanent placements for healthcare providers.
BDSX
Biodesix
$288.33Mn
27.33
-8.38%
+256.32%
Biodesix operates as a diagnostic solutions company that provides blood-based tests, such as Nodify CDT and VeriStrat, to healthcare providers for lung cancer risk assessment and treatment guidance. Its primary revenue source is Lung Diagnostic Testing, which bills for the performance of these clinical tests on patient samples.
INFU
InfuSystem Holdings
$254.10Mn
12.76
-1.01%
+24.25%
InfuSystem operates as a healthcare service provider delivering outpatient care solutions, specifically managing infusion therapies and equipment for oncology practices, ambulatory surgery centers, and other alternate site providers. Its revenue is derived from billing payers and facilities for these outpatient services and the associated equipment use.
SEER
2nd
Seer
$243.93Mn
2.20
-1.35%
+0.00%
Through its Seer Technology Access Centers (STACs), the company provides fee-for-service access to its proteomic workflow, delivering diagnostic-grade data to researchers on a pay-per-use basis.
AGPU
2nd
Axe Compute
$224.81Mn
11.42
+0.44%
-16.52%
The company operates a clinical testing division that provides CLIA certified services, including Tumor Drug Response Testing and Genomic Profiling, to physicians and cancer patients.
AMWL
2nd
American Well
$216.30Mn
12.78
-5.89%
+106.80%
The company operates the Amwell Medical Group network, which provides licensed clinicians to deliver virtual visits on a fee-for-service basis.
XGN
Exagen
$190.88Mn
7.89
-2.95%
-28.14%
Exagen operates a CLIA-certified and CAP-accredited laboratory in Vista, California, where it performs high-complexity diagnostic testing for autoimmune diseases. Its revenue is primarily generated from providing these clinical laboratory services, specifically through its AVISE® CTD and AVISE® Lupus tests, which are billed to insurers, Medicare, and Medicaid.
IDXG
Interpace Biosciences
$177.01Mn
6.39
+0.00%
—
Interpace Biosciences operates a CLIA-certified and CAP-accredited laboratory where it performs molecular diagnostic testing and pathology services on patient biopsies. Its revenue is derived from providing these diagnostic-testing services and billing payers like Medicare and commercial insurers for tests such as ThyGeNEXT® and ThyraMIR® v2.
STIM
2nd
Neuronetics
$169.15Mn
2.22
-5.13%
-18.38%
The company operates the Greenbrook network of company-owned treatment centers, which deliver outpatient mental health care including NeuroStar therapy and SPRAVATO nasal spray to patients.
BNR
Burning Rock Biotech
$168.19Mn
15.99
-9.30%
+84.43%
Burning Rock Biotech operates a central laboratory model where it processes tissue and liquid biopsy samples from partner hospitals and issues diagnostic reports. Its primary revenue is derived from providing these next-generation sequencing-based cancer therapy selection and early detection testing services.
NAKA
2nd
Nakamoto
$163.02Mn
9.11
-3.70%
-79.85%
The Healthcare Operations segment provides outpatient medical services including behavioral therapy, addiction recovery, and weight loss programs delivered through clinics.
QTRX
2nd
Quanterix
$160.73Mn
3.41
-8.09%
-38.45%
The company operates a CLIA certified Accelerator Laboratory that provides clinical laboratory testing services and LDTs, such as LucentAD Complete and Simoa NfL, to hospital networks and reference labs.
INGN
2nd
Inogen
$159.85Mn
5.98
+13.47%
-28.98%
The company operates a direct-to-consumer rental model for its oxygen concentrators and provides clinical support and billing assistance for home use, delivering care and equipment where the patient lives.
WW
2nd
Ww International
$137.15Mn
13.72
-11.25%
-47.07%
The company's Clinical business, Med+, delivers telehealth-based access to board-certified doctors and clinicians who provide medication prescribing and care navigation for obesity medicine.
LFMD
LifeMD
$136.29Mn
2.85
-1.72%
-57.78%
LifeMD operates as a direct-to-patient healthcare company providing virtual medical care across primary care, men's and women's health, and weight management. Its revenue is primarily driven by recurring subscription fees for virtual clinical services and consultations provided by affiliated providers.
NRXP
2nd
NRX Pharmaceuticals
$123.00Mn
2.85
-2.40%
-14.67%
The company owns HOPE Therapeutics, a medical services organization that operates five clinical sites providing outpatient interventional psychiatry care, including ketamine infusions and transcranial magnetic stimulation.
AIRS
Airsculpt Technologies
$121.58Mn
1.70
-3.41%
-79.06%
AirSculpt operates a network of company-owned clinics where it delivers minimally invasive body contouring, fat removal, and skin tightening procedures. These are outpatient healthcare services provided in a clinic setting, with revenue generated from per-procedure fees charged to patients.
LUCD
Lucid Diagnostics
$120.18Mn
0.63
-16.00%
-38.24%
Lucid Diagnostics operates a CLIA certified laboratory through its subsidiary LucidDx Labs that performs the EsoGuard assay. The company generates revenue by billing Medicare, private insurers, and patients for each diagnostic test performed on patient samples.
VSEE
2nd
Vsee Health
$116.93Mn
2.10
-6.67%
+238.71%
Through its iDoc subsidiary, the company delivers clinical care by supplying board-certified physicians in neurology, cardiology, and pulmonary critical care to hospitals and correctional institutions via a secure video platform.
IMDX
2nd
Insight Molecular Diagnostics
$113.20Mn
3.47
-3.34%
+5.47%
The company operates a CLIA certified facility in Franklin, Tennessee, where it performs the GraftAssureCore laboratory developed test as a service for customers.
JYNT
Joint
$106.07Mn
7.47
+0.95%
-19.42%
JOINT Corp operates and franchises chiropractic clinics that deliver outpatient care in a retail environment. The company generates revenue from its own clinics and through royalties from franchisees who provide routine adjustments to patients.
SERA
Sera Prognostics
$102.97Mn
2.04
-2.39%
-30.85%
Sera Prognostics provides clinical diagnostic testing services through its PreTRM blood-based biomarker test. The company generates revenue from the administration of these tests to patients, with payments coming from healthcare providers and reimbursement from insurers like Elevance Health.
SLQT
2nd
SelectQuote
$75.88Mn
0.43
+4.88%
-78.06%
The company's Healthcare Services segment, specifically SelectPatient Management (SPM), provides chronic care management and health navigation services to help patients navigate the care continuum.
MYO
2nd
Myomo
$62.26Mn
1.62
+5.88%
+76.09%
The company earns revenue from clinical services including evaluation, measurement, fitting, and training when acting as the provider in its direct billing model.
POSC
2nd
Positron
$58.79Mn
1.79
+3.47%
+27.86%
The company provides clinical over-read support and billing/prior-authorization assistance to healthcare providers, which are outpatient-style healthcare services delivered to support the diagnosis and treatment of patients.
DRIO
2nd
DarioHealth
$57.56Mn
6.16
-6.95%
-64.14%
The company delivers clinical care and chronic condition management remotely through a combination of connected devices and behavior change coaching. It earns revenue via per-member-per-month contracts from health plans and employers to provide virtual care for diabetes, hypertension, and mental health.
LFS
2nd
Leifras
$54.94Mn
2.10
+1.45%
-32.48%
The company's Social Business segment operates after-school daycare services for children with developmental needs and delivers exercise programs for the elderly at healthcare facilities.
BTMD
Biote
$47.73Mn
1.16
-4.13%
-61.07%
The company provides a practice-building platform for hormone optimization, including education, training, and clinical decision support for practitioners in clinics. It enables clinicians to establish and grow hormone optimization programs within their existing outpatient clinics, which aligns with the delivery of healthcare services outside of hospitals.
NNOX
2nd
Nano-X Imaging
$45.93Mn
0.66
-4.35%
-82.11%
The company operates the Nanox. MARKETPLACE, which provides teleradiology services by connecting healthcare facilities with remote radiology expertise for scan readings.
PIII
P3 Health Partners
$45.73Mn
6.30
-6.80%
-28.41%
P3 Health Partners operates as a population health management company that delivers outpatient care through a network of affiliated independent primary care providers. It provides clinical oversight, care coordination, and chronic disease management for Medicare Advantage members in a clinic setting.
ACH
Accendra Health
$43.07Mn
0.56
-3.45%
-88.84%
Accendra Health is a nationwide provider of home-based healthcare solutions, delivering care and products in non-acute settings. Its core business focuses on serving patients in their homes through offerings like sleep therapy, home respiratory therapy, and diabetes care.
SY
So-Young International
$41.63Mn
2.70
+1.12%
-29.13%
The company operates a network of branded aesthetic centers that deliver non-surgical procedures such as laser therapies and ultrasound facelifts. Revenue is generated from service fees for aesthetic treatments performed at these outpatient clinic settings.
SHFH
2nd
Scientist Home Future Health
$41.50Mn
1.75
+0.00%
—
The company provides physical check-up services and in-person health consultations at its physical locations in Hong Kong. These are outpatient healthcare services delivered in a clinic-like setting rather than a hospital or the patient's home.
PRPO
Precipio
$40.67Mn
22.73
-4.01%
+10.88%
Precipio operates two full-service laboratories that provide specialized cancer diagnostic testing, including molecular diagnostics and cytogenetics, to physicians and hospitals. This division generates recurring service revenue reimbursed by Medicare, Medicaid, and private insurers.
DCGO
DocGo
$38.55Mn
0.39
-2.50%
-70.23%
DocGo provides medical care, diagnostics, triage, and treatment in non-traditional locations such as workplaces and other outpatient settings. Its Mobile Health Services segment specifically offers population health and chronic disease management for underserved communities, which fits the description of healthcare services delivered outside of inpatient hospitals.
RYOJ
rYojbaba
$34.65Mn
3.00
+0.00%
+57.89%
The company's primary revenue source (83%) comes from its Health Services segment, which operates twenty-nine osteopathic clinics providing outpatient treatments such as acupuncture, posture correction, and pelvic correction. These services are delivered in a clinic setting to individual patients seeking treatment for musculoskeletal pain and chronic conditions.
CCEL
Cryo Cell International
$32.65Mn
4.05
-3.57%
-11.96%
The company's core business is the collection, processing, testing, and long-term cryogenic storage of umbilical cord blood and tissue stem cells. These activities constitute clinical laboratory and diagnostic testing services, with revenue generated from processing and storage fees.
EUDA
EUDA Health Holdings
$30.08Mn
15.91
+13.56%
-60.03%
The company provides non-invasive healthcare and wellness services, specifically selling bioenergy cabin therapy packages and stem cell therapy services to individual consumers. These are delivered as outpatient/clinic-style services rather than in a hospital or home setting.
MDXH
MDxHealth
$29.79Mn
0.58
+0.00%
-87.61%
MDxHealth operates a CLIA accredited CAP certified laboratory network to provide clinical diagnostic testing services. It generates revenue by performing tests such as Confirm mdx, GPS mdx, and Exo mdx on patient samples and delivering results to urology clinics and pathology laboratories.
ETST
2nd
Earth Science Tech
$25.88Mn
0.09
+0.00%
-47.06%
The company operates Peaks Curative, a telemedicine referral platform that offers asynchronous consultations for patients seeking compounded medications.
COSM
2nd
Cosmos Health
$23.37Mn
0.39
-9.30%
-64.55%
The company operates the ZipDoctor platform, which is a direct-to-consumer subscription service providing 24/7 remote access to board-certified physicians and mental-health counsellors.
EHTH
eHealth
$22.10Mn
0.69
-2.82%
-83.45%
eHealth operates a technology and service platform that provides remote health insurance enrollment solutions and consumer engagement education. It employs a model where it facilitates the selection and enrollment of Medicare and individual/family health plans remotely, earning commissions from insurance carriers for these services.
BNGO
2nd
Bionano Genomics
$18.49Mn
1.57
+0.64%
-9.77%
The company operates Bionano Laboratories, which provides diagnostic testing services to clinicians and hospital genetics departments.
GBCS
Selectis Health
$17.57Mn
5.73
-0.17%
+154.67%
Selectis Health operates an owner-operator model where it directly manages the operations of assisted living, independent living, and skilled nursing facilities. It receives payments from private pay residents, Medicare, Medicaid, and managed care contracts for delivering these care services.
AAQL
2nd
Antiaging Quantum Living
$17.48Mn
0.51
+0.00%
-45.74%
The company's PRC subsidiaries generate income from nonmedical health management and consulting activities provided through the Dao Ling Doctor brand.
LDDD
Longduoduo
$15.31Mn
0.51
+0.00%
-53.64%
The company provides preventive healthcare services, including disease screening and treatments for cardiovascular and cerebrovascular diseases, delivered through its subsidiaries and agency relationships. It specifically offers outpatient-style services such as meridian regulating, double blood purification, and microwave therapy to individual consumers.
PMDI
Psychemedics
$15.21Mn
2.49
+0.00%
+17.45%
Psychemedics provides clinical laboratory and diagnostic testing services, specifically analyzing hair samples for drugs of abuse and health markers. Its revenue is derived from charging fees for screening and confirmation testing for customers such as employers, schools, and parents.
ADIA
2nd
Adia Nutrition
$14.16Mn
0.15
+15.38%
+275.00%
The company operates Adia Med clinics that deliver regenerative therapies to patients in an outpatient setting for orthopedic conditions, pain management, and wound repair.
KPEA
2nd
Kun Peng International
$13.20Mn
0.33
+0.00%
-57.69%
The company provides health screening services and personalized health monitoring, which are delivered as outpatient/clinic-style healthcare services to its members.
CNSY
2nd
Cerenome
$13.01Mn
1.78
-4.81%
-89.53%
The company operates a CLIA certified laboratory through its subsidiary CNSide Diagnostics LLC, which provides clinical diagnostic testing services via the CNSide Cerebrospinal Fluid Tumor Cell Enumeration test. It generates current revenue from these laboratory-developed tests reimbursed by payers like UnitedHealthcare and Humana.
CCM
Concord Medical Services Holdings
$12.81Mn
2.95
-9.79%
-51.95%
The company operates self-owned cancer hospitals and clinics that provide inpatient and surgical oncology care, including radiotherapy, chemotherapy, and surgical treatments. This is presented as a primary business segment delivering comprehensive care directly to patients.
SYRA
Syra Health
$12.32Mn
0.89
+1.14%
+1,012.50%
Syra Health provides comprehensive healthcare services including population health management, behavioral and mental health services, and health education. These services are delivered to hospitals, state health departments, and managed care entities, fitting the description of outpatient and specialty care networks.
PFHO
2nd
Pacific Health Care Organization
$12.03Mn
0.94
-6.00%
-19.66%
The company provides medical case management and employee advocate services, which involve coordinating treatment plans and supporting injured workers in an outpatient/clinic context to facilitate their return to work.
AWHL
Aspira Women's Health
$10.73Mn
0.23
+0.00%
-54.90%
Aspira generates revenue by performing diagnostic tests (Ova1Plus and OvaWatch) at its own CLIA-certified laboratory, Aspira Labs. It bills third-party payers, including Medicare and Medicaid, for these clinical laboratory services.
MEDS
2nd
DataMeds AI
$9.70Mn
4.06
+28.08%
-90.38%
The company operates Wellgistics Pharmacy, which provides specialty and general pharmacy services, including patient care coordination and clinical services.
AMS
American Shared Hospital Services
$9.41Mn
1.42
+0.00%
-42.74%
The company operates its own treatment facilities that deliver radiosurgery and radiation therapy directly to patients in locations such as Rhode Island, Peru, and Mexico. This activity constitutes delivering specialty healthcare services in an outpatient or clinic setting, which is the core of the Direct Patient Services segment.
MGRX
Mangoceuticals
$8.65Mn
0.48
+11.63%
-77.25%
Mangoceuticals operates a telehealth platform that connects consumers with licensed healthcare professionals for consultations. Its revenue model includes consultation fees and the associated pharmacy fulfillment of prescriptions for men's health conditions.
XWEL
2nd
Xwell
$6.95Mn
0.82
-2.38%
-17.17%
The XpresTest segment provides bio-surveillance monitoring and pathogen sample collection services in partnership with government health agencies, which constitutes outpatient healthcare services.
HLYK
2nd
HealthLynked
$6.85Mn
2.32
+16.00%
+29.61%
The company provides on-demand telemedicine services and generates revenue from telemedicine visits, delivering clinical care and prescriptions to patients remotely.
TANAF
2nd
Tian'an Technology
$6.37Mn
0.14
+55.56%
-99.11%
Through its subsidiary Henan Qige, the company provides healthcare services including personalized health consultations and guided therapy sessions to individuals, wellness centers, and clinics.
CDIO
2nd
Cardio Diagnostics Holdings
$5.68Mn
1.92
+1.05%
-54.93%
The company operates its own CLIA certified high complexity testing laboratory to provide laboratory services for its diagnostic tests.
GRDN
2nd
Guardian Pharmacy Services
$5.18Mn
40.86
+0.07%
+67.80%
The company provides clinical consultation, medication therapy management, and adherence monitoring specifically for residents of assisted living, behavioral health, and skilled nursing facilities. These services are delivered directly to patients where they live in residential care settings.
AIDX
20
$5.02Mn
0.41
-6.82%
—
The company operates a CAP accredited CLIA licensed laboratory and generates the majority of its revenue from providing clinical diagnostic blood tests, specifically the OneTest for Cancer and OneTest for Longevity. It bills for these diagnostic-testing services provided to consumers, employers, and retail clinics.
PMHS
2nd
Polomar Health Services
$4.81Mn
0.17
+0.00%
-15.00%
The company owns SlimRx, an online platform that connects patients with licensed physicians to prescribe weight loss treatments, and is launching PoloMeds for diabetes and dermatological prescriptions.
BMGL
Basel Medical
$4.73Mn
3.02
-3.21%
-85.41%
Basel Medical Group Ltd operates a network of medical clinics in Singapore providing outpatient services including general practice, orthopedic care, neurosurgical treatments, and mental health services. Revenue is generated from fees for medical consultations, diagnostic tests, and therapeutic treatments delivered in these clinic settings.
LFST
LifeStance Health
$4.38Mn
11.91
-1.00%
+118.53%
LifeStance Health operates as an outpatient mental health platform providing psychiatric evaluations, therapy, and psychological testing through a network of 572 physical centers. Its revenue is generated on a per-visit basis from commercial insurers, government payors, and self-pay patients for care delivered in these clinic settings.
RHEP
Regional Health Properties
$4.00Mn
1.02
-6.42%
-36.65%
The company directly operates skilled nursing and senior housing communities, providing sub-acute, post-acute, and memory care services. These activities are delivered in residential settings where the patients live, which is the defining characteristic of H-15.
BICX
2nd
BioCorRx
$3.63Mn
0.21
-16.00%
+0.00%
BioCorRx provides the Beat Addiction Recovery Program and UnCraveRx Weight Loss Management Program to healthcare providers, clinics, and addiction treatment centers, delivering behavioral health and wellness services in an outpatient/clinic setting.
INBS
2nd
Intelligent Bio Solutions
$2.49Mn
1.69
+1.20%
-83.75%
The company generates additional revenue from confirmatory testing services where samples are sent to third party laboratories for analysis.
VYCO
2nd
Vycor Medical
$2.34Mn
0.07
+0.00%
-58.82%
Through its NovaVision unit, the company provides non-invasive vision rehabilitation therapies, such as Vision Restoration Therapy and NeuroEyeCoach, to patients and rehabilitation clinics.
ACUT
Accustem Sciences
$2.25Mn
0.14
+0.00%
-91.72%
AccuStem Sciences provides clinical diagnostic testing services, specifically genomic tests for cancer care such as the MSC test for lung nodules and the StemPrintER test for breast cancer. Its revenue model is based on reimbursement from insurers and payments from healthcare providers for performing these diagnostic tests.
BGLC
2nd
BioNexus Gene Lab
$2.23Mn
1.20
-1.64%
-78.10%
Through MRNA Scientific, the company operates laboratories in Kuala Lumpur and Penang that provide clinical diagnostic testing services. It earns fees for conducting blood sample analyses to detect RNA biomarkers for diseases such as cancer and cardiovascular risks, serving hospitals, clinics, and corporate clients.
VVOS
2nd
Vivos Therapeutics
$2.18Mn
0.15
+0.00%
-95.30%
The company operates Sleep and Airway Medicine Centers that provide diagnostic and treatment services, including sleep testing, and manages sleep medical practices via management services organizations.
BIAF
bioAffinity Technologies
$2.14Mn
6.14
-6.40%
-85.89%
The company generates its primary revenue through the sale of CyPath® Lung tests, which are performed by its wholly owned subsidiary PPLS, a CLIA-certified clinical laboratory. It provides diagnostic and lab-testing services to physicians to detect early-stage lung cancer.
IVF
INVO Fertility
$2.07Mn
0.90
-1.10%
-97.07%
The company operates fertility clinics, including INVO Centers and the Wisconsin Fertility Institute, providing services such as in vitro fertilization and intrauterine insemination. It generates its primary revenue from patient fees for these outpatient fertility clinic services.
CDIX
Cardiff Lexington
$1.99Mn
0.10
-28.57%
-97.78%
The company operates Nova, which provides outpatient specialty care, interventional pain management, and diagnostic/surgical services for skeletal injuries across twelve facilities. These services are delivered in a clinic/ambulatory setting rather than an inpatient hospital or the patient's home.
LUDG
Ludwig Enterprises
$1.67Mn
0.01
+0.00%
-83.33%
Ludwig Enterprises generates revenue through laboratory analysis services for its Laboratory Developed Tests, such as the Revealia™ Breast test. The company provides clinical diagnostic testing services using mRNA biomarkers to detect inflammation-related chronic diseases and cancers.
WLSS
Welsis
$1.65Mn
0.60
+0.00%
-82.86%
Welsis provides online psychological help services, teletherapy, and telepsychology through a telehealth platform. It generates revenue from fees charged for professional psychological consultations delivered via mobile devices, video, and phone calls.
DOGP
2nd
Dogecoin Cash
$1.63Mn
0.01
+0.00%
-66.67%
The company operates a telemedicine service that connects patients with licensed physicians for remote medical evaluations via secure video, which is the core delivery mechanism of its business.
BTCY
2nd
Biotricity
$1.41Mn
0.07
+16.67%
-86.79%
The company provides remote patient monitoring services and virtual clinic capabilities through its Biocare platform and Bioheart direct-to-consumer monitor, delivering clinical data and monitoring to patients remotely.
YBGJ
2nd
Yubo International Biotech
$1.20Mn
0.01
+0.00%
+0.00%
The company operates a segment for stem cell testing and health management consulting, providing laboratory-based cell testing to assess viability and potency for clients.
LGMK
2nd
LogicMark
$989.73K
1.10
+6.80%
-51.11%
LogicMark provides monitored safety services where users pay recurring monthly fees for 24/7 emergency response center services and remote monitoring via 4G LTE and GPS.
PAIYY
Aesthetic Medical International Holdings
$982.18K
0.02
+0.00%
-89.47%
The company primarily operates a network of treatment centers providing non-surgical aesthetic medical services (69.6%-74.9% of revenue) and surgical aesthetic treatments (16.3%-21.0% of revenue) in an outpatient/clinic setting. These services include Botox injections, hyaluronic acid injections, and laser treatments delivered through its strategically established centers.
AGSS
2nd
Ameriguard Security Services
$893.48K
0.01
+0.00%
-50.00%
Through its subsidiary TransportUS, Inc., the company provides ambulatory and non-ambulatory patient transportation services for the Veterans Administration. This healthcare service segment generated approximately $9 million in annual revenue.
RMTG
2nd
Regenerative Medical Technology
$824.34K
0.06
+0.00%
+50.00%
The company directly performs patient procedures and delivers regenerative medicine treatments at its own clinics in Cancun, Mexico, and a planned facility in Dubai.
POM
Pomdoctor
$484.03K
0.90
-6.25%
-98.76%
Pomdoctor operates an 'Internet Hospital' segment that provides remote medical consultations, prescription renewals, and chronic disease management via a mobile app and WeChat. It employs or contracts a network of over 212,000 doctors to deliver clinical care and prescriptions to patients remotely.
FCHS
First Choice Healthcare Solutions
$329.58K
0.01
+0.00%
+0.00%
The company operates a national chain of medical functional health and wellness clinics (Live Well Medical Group) providing primary care, chronic disease management, and wellness services. Revenue is generated from insured primary care visits reimbursed by Medicare, Medicaid, and commercial insurers, as well as self-pay wellness therapies.
MNDR
Mobile-health Network Solutions
$187.49K
1.27
-4.51%
-94.59%
The company operates the MaNaDr platform, which delivers medical consultations and remote patient monitoring via a mobile application and website. Its primary revenue is generated from fees for teleconsultation services provided to individual patients and corporate employees.
PRPH
2nd
ProPhase Labs
$155.93K
0.01
+0.00%
-99.81%
The company provides diagnostic laboratory services and clinical assays through its ProPhase Diagnostics segment, serving patients and healthcare providers via CLIA-certified laboratories.
FOXO
Foxo Technologies
$137.98K
0.10
-16.67%
-98.81%
The company operates Big South Fork Medical Center, a 25-bed Critical Access Hospital providing 24/7 emergency care, inpatient services, and ancillary radiology and pharmacy services. This inpatient facility operation is a core component of its Healthcare segment.
GVHGF
Visionary Holdings
$43.34K
0.01
+0.00%
-99.53%
The company provides high-end medical aesthetics services, anti-aging treatments like the Cell Regeneration Project, and intestinal maintenance and physiotherapy services. These are delivered as outpatient clinical services to individuals seeking wellness and aesthetic interventions.
NIVF
NewGenIvf
$2.68K
0.10
-41.18%
-99.99%
NewGenIvf operates fertility clinics in Thailand, Cambodia, and Kyrgyzstan, providing outpatient medical procedures such as IVF, embryo transfer, and egg donation. These are specialty care services delivered in a clinic setting, which aligns with the Healthcare Services industry.
ADTX
2nd
Aditxt
$0.00
0.00
—
-100.00%
The company operates a high-complexity CLIA CAP accredited laboratory in Richmond Virginia to support assay development and has licensed antibody testing to other CLIA CAP certified laboratories.
BACK
IMAC Holdings
$0.00
0.00
—
-100.00%
IMAC Holdings operates a CLIA-certified and CAP-accredited laboratory that provides clinical diagnostic testing services, specifically the Ignite RPPA Assay for Breast Cancer. It generates revenue from these diagnostic-testing service fees paid by private insurers and healthcare providers.
EHVVF
2nd
Ehave
$0.00
0.00
—
—
Through its subsidiary KetaDash, the company delivers clinical care and prescriptions remotely, specifically providing at-home Ketamine treatments and IV therapies for patients with mental illnesses.
KAYS
2nd
Kaya Holdings
$0.00
0.00
—
-100.00%
The company operates The Sacred Mushroom Psychedelic Treatment Center, which provides supervised psilocybin sessions and integration support for clients with PTSD, addiction, and eating disorders in a clinical setting.
MCLE
Medicale
$0.00
0.00
—
-100.00%
The company's name 'Medicale' and its placement in the Healthcare sector suggest a focus on healthcare delivery, and H-14 is the most general category for outpatient healthcare services. However, the profile explicitly states the company has not yet commenced operations, identified any products, or generated revenue.
